TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway

Oncogene

Volumn 24, Issue 25, 2005, Pages 4052-4064

  Wendt, Jana ^a   Von Haefen, Clarissa ^a   Hemmati, Philipp ^a,b   Belka, Claus ^c   Dörken, Bernd ^a,b   Daniel, Peter T ^a,b,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Apoptosis; Bax; Ionizing irradiation; Mitochondrial pathway; Synergy; TRAIL

Indexed keywords

CASPASE 3; CASPASE 9; DNA; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CROSS ALLERGY; DNA DAMAGE; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IONIZING RADIATION; MITOCHONDRION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; GAMMA RAYS; HUMANS; INTRACELLULAR MEMBRANES; MALE; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21244493984     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208580     Document Type: Article

References (62)

1. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
2. Ballestrero A, Nencioni A, Boy D, Rocco I, Garuti A, Mela GS, Van Parijs L, Brossart P, Wesselborg S and Patrone F. (2004). Clin. Cancer Res., 10, 1463-1470.
3. Belka C, Rudner J, Wesselborg S, Stepczynska A, Marini P, Lepple-Wienhues A, Faltin H. Bamberg M, Budach W and Schulze-Osthoff K. (2000). Oncogene, 19, 1181-1190.
4. Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K and Budach W. (2001). Oncogene, 20, 2190-2196.
5. Bonavida B, Ng CP, Jazirehi A, Schiller G and Mizutani Y. (1999). Int. J. Oncol., 15, 793-802.
6. Bosanquet AG, Sturm I, Wieder T, Essmann F, Bosanquet MI, Head DJ, Dörken B and Daniel PT. (2002). Leukemia, 16, 1035-1044.
7. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW and Vogelstein B. (1999). J. Clin. Invest., 104, 263-269.
8. Cartron P-F, Juin P, Oliver L, Martin S, Meflah K and Vallette FM. (2003). Mol. Cell. Biol., 23, 4701-4712.
9. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ and Korsmeyer SJ. (2003). Science, 301, 513-517.
10. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T and Korsmeyer SJ. (2001). Mol. Cell, 8, 705-711.
11. Coney LR, Daniel PT, Sanborn D, Dhein J, Debatin KM, Krammer PH and Zurawski Jr VR. (1994). Int. J. Cancer, 58, 562-567.
12. Daniel PT, Schulze-Osthoff K, Belka C and Güner D. (2003). Essays Biochem., 39, 73-88.
13. Daniel PT, Sturm I, Wieder T and Schulze-Osthoff K. (2001). Leukemia, 15, 1022-1032.
14. Deng Y, Lin Y and Wu X. (2002). Genes Dev., 16, 33-45.
15. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P and Krammer PH. (1992). J. Immunol., 149, 3166-3173.
16. Eberle J, Fecker LF, Hossini AM, Wieder T, Daniel PT, Orfanos CE and Geilen CC. (2003). Oncogene, 22, 9131-9141.
17. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Janicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K and Wesselborg S. (2000). Oncogene, 19, 4563-4573.
18. Eskes R, Desagher S, Antonsson B and Martinou JC. (2000). Mol. Cell. Biol., 20, 929-935.
19. Essmann F, Wieder T. Otto A, Muller EC, Dörken B and Daniel PT. (2000). Biochem. J., 346, 777-783.
20. Friedrich K, Wieder T, von Haefen C, Radetzki S, Jänicke R, Schulze-Osthoff K, Dörken B and Daniel PT. (2001). Oncogene, 20, 2749-2760.
21. Fulda S, Meyer E and Debatin KM. (2002). Oncogene, 21, 2283-2294.
22. Gillissen B, Essmann F, Graupner V, Stärck L, Radetzki S, Dörken B, Schulze-Osthoff K and Daniel PT. (2003). EMBO J., 22, 3580-3590.
23. Gliniak B and Le T. (1999). Cancer Res., 59, 6153-6158.
24. Güner D, Sturm I, Hemmati PG, Hermann S, Hauptmann S, Wurm R, Budach V, Dörken B, Lorenz M and Daniel PT. (2002). Int. J. Cancer, 103, 445-454.
25. Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B and Daniel PT. (2004). Oncogene, 23, 4523-4535.
26. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B and Daniel PT. (2002). Oncogene, 21, 3149-3161.
27. Klöpfer A, Hasenjäger A, Belka C, Schulze-Osthoff K, Dörken B and Daniel PT. (2004). Oncogene, 23, 9408-9418.
28. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ and Schlesinger PH. (2000). Cell Death Differ., 7, 1166-1173.
29. LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D and Ashkenazi A. (2002). Nat. Med., 8, 274-281.
30. Lucking-Famira KM, Daniel PT, Moller P, Krammer PH and Debatin KM. (1994). Leukemia, 8, 1825-1833.
31. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. (1998). Cell, 94, 481-490.
32. Marini P, Jendrossek V, Durand E, Gruber C, Budach W and Belka C. (2003). Radiother. Oncol., 68, 189-198.
33. Martinou JC and Green DR. (2001). Nat. Rev. Mol. Cell Biol., 2, 63-67.
34. Mrozek A, Petrowsky H, Sturm I, Krauss J, Hermann S, Hauptmann S, Lorenz M and Daniel P. (2002). Cell Death Differ., 10, 461-467.
35. Newton K and Strasser A. (2000). J. Exp. Med., 191, 195-200.
36. Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig W-D, Henze G, Dörken B and Daniel PT. (2000). Leukemia, 14, 1606-1613.
37. Prokop A, Wrasidlo W, Lode H, Herold R, Lang F, Henze G, Dörken B, Wieder T and Daniel PT. (2003). Oncogene, 22, 9107-9120.
38. Radetzki S, Köhne CH, von Haefen C, Gillissen B, Sturm I, Dörken B and Daniel PT. (2002). Oncogene, 21, 227-238.
39. Raisova M, Bektas M, Wieder T, Daniel P, Eberle J, Orfanos CE and Geilen CC. (2000). FEBS Lett., 473, 27-32.
40. Raisova M, Hossini A, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE and Geilen CC. (2001). J. Invest. Dermatol., 177, 333-340.
41. Rudner J, Jendrossek V, Lauber K, Daniel PT, Wesselborg S and Belka C. (2005). Oncogene, 24, 130-140.
42. Schelwies K, Sturm I, Grabowski P, Scherübl H, Schindler I, Hermann S, Stein H, Buhr HJ, Riecken EO, Zeitz M, Dörken B and Daniel PT. (2002). Int. J. Cancer, 99, 589-596.
43. Schmelz K, Wieder T, Tamm I, Müller A, Essmann F, Geilen CC, Schulze-Osthoff K, Dörken B and Daniel PT. (2004). Oncogene, 23, 6743-6759.
44. Slee EA, Keogh SA and Martin SJ. (2000). Cell Death Differ., 7, 556-565.
45. Sturm I, Bosanquet A, Hermann S, Güner D, Dörken B and Daniel P. (2002). Cell Death Differ., 10, 477-484.
46. Sturm I, Kohne CH, Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, Lorenz M, Dörken B and Daniel PT. (1999). J. Clin. Oncol., 17, 1364-1374.
47. Sturm I, Papadopoulos S, Hillebrand T, Benter T, Lück H-J, Wolff G, Dörken B and Daniel PT. (2000). Int. J. Cancer, 87, 517-521.
48. Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzki S, Hillebrand T, Wolff G, Hauptmann S, Dörken B and Daniel PT. (2001). J. Clin. Oncol., 19, 2272-2281.
49. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ and Vandenabeele P. (2002). Cell Death Differ., 9, 1031-1042.
50. von Haefen C, Gillissen B, Hemmati PG, Wendt J, Güner D, Mrozek A, Belka C, Dörken B and Daniel PT. (2004). Oncogene, 23, 8320-8332.
51. von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dörken B and Daniel PT. (2003). Oncogene, 22, 2236-2247.
52. von Haefen C, Wieder T, Gillissen B, Stärck L, Graupner V, Dörken B and Daniel PT. (2002). Oncogene, 21, 4009-4019.
53. Walczak H, Bouchon A, Stahl H and Krammer PH. (2000). Cancer Res., 60, 3051-3057.
54. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
55. Waldman T, Lengauer C, Kinzler KW and Vogelstein B. (1996). Nature, 381, 713-716.
56. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ. (2001). Science, 292, 727-730.
57. Wen J, Ramadevi N, Nguyen D, Perkins C, Worthington E and Bhalla K. (2000). Blood, 96, 3900-3906.
58. Wesselborg S, Engels IH, Rossmann E, Los M and Schulze-Osthoff K. (1999). Blood, 93, 3053-3063.
59. Wieder T, Essmann F, Prokop A, Schmelz K, Schulze-Osthoff K, Beyaert R, Dörken B and Daniel PT. (2001). Blood. 97, 1378-1387.
60. Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X and Shi Y. (2000). Nature, 408, 1008-1012.
61. Yu J, Wang Z, Kinzler KW, Vogelstein B and Zhang L. (2003). Proc. Natl. Acad. Sci. USA, 100, 1931-1936.
62. Zhang L, Yu J, Park BH, Kinzler KW and Vogelstein B. (2000). Science, 290, 989-992.